// App-Quantinova.ai

OC 34.3 : Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolism: a score to identify high risk patients

Researchers

Presenter

  • J. CATELLA

Principal Investigators

  • L. Bertoletti

  • F. Moustapha

  • J. Nieto

  • R. Valle

  • I. Quere

  • M. Monreal

Medical Centers

  • Hospices Civils de Lyon, LYON, Rhone-Alpes, France

  • CHU Saint Etienne, Saint-Etienne, Rhone-Alpes, France

  • CHU Clermont Ferrand, Clermont Ferrand, Auvergne, France

  • Hospital General Virgen de la Luz, Cuenca., Andalucia, Spain

  • Hospital Sierrallana, Santander, Cantabria, Spain

  • Hospital Clínico San Carlos, Madrid, Andalucia, Spain

  • Hospital Regional Universitario de Malaga, Malaga, Spain

  • Hopital St Eloi, montpellier, Provence-Alpes-Cote d'Azur, France

  • Hopital la Timone, Marseille, Provence-Alpes-Cote d'Azur, France

  • Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain Chair for the Study of Thromboembolic Disease, Faculty of Health Sciences, UCAM - Universidad Católica San Antonio de Murcia, Spain, Barcelona, Andalucia, Spain

Locations

  • France

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Gastroenterology (GU)

Disease

  • Gastrointestinal bleeding

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A